Literature DB >> 1350302

A variable number of tandem repeats locus within the human complement C2 gene is associated with a retroposon derived from a human endogenous retrovirus.

Z B Zhu1, S L Hsieh, D R Bentley, R D Campbell, J E Volanakis.   

Abstract

We have previously described multiallelic restriction fragment length polymorphisms of the C2 gene, suggesting the presence of a variable number of tandem repeats (VNTR) locus. We report here the cloning and sequencing of the polymorphic fragments from the two most common alleles of the gene, a and b. The results confirm the presence of a VNTR locus consisting of a nucleotide sequence, 41 bp in average length, repeated tandemly 23 and 17 times in alleles a and b, respectively. The difference in the number of repeats between the two alleles is due to the deletion/insertion of two noncontiguous segments, 143 and 118 bp long, of allele a, and of a 40-bp segment of allele b. The VNTR region is associated with a SINE (short interspersed sequence)-type retroposon, SINE-R.C2, located within the third intron of the C2 gene. SINE-R.C2 is a member of a previously described large retroposon family of the human genome, apparently derived from the human endogenous retrovirus, (HERV) K10, which is homologous to the mouse mammary tumor virus.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1350302      PMCID: PMC2119228          DOI: 10.1084/jem.175.6.1783

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  19 in total

1.  Human major histocompatibility complex contains a minimum of 19 genes between the complement cluster and HLA-B.

Authors:  T Spies; M Bresnahan; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

Review 2.  Nonviral retroposons: genes, pseudogenes, and transposable elements generated by the reverse flow of genetic information.

Authors:  A M Weiner; P L Deininger; A Efstratiadis
Journal:  Annu Rev Biochem       Date:  1986       Impact factor: 23.643

3.  Allelic associations of multiple RFLPs of the gene encoding complement protein C2.

Authors:  Z B Zhu; J E Volanakis
Journal:  Am J Hum Genet       Date:  1990-05       Impact factor: 11.025

4.  Minisatellite repeat coding as a digital approach to DNA typing.

Authors:  A J Jeffreys; A MacLeod; K Tamaki; D L Neil; D G Monckton
Journal:  Nature       Date:  1991-11-21       Impact factor: 49.962

5.  A novel human nonviral retroposon derived from an endogenous retrovirus.

Authors:  M Ono; M Kawakami; T Takezawa
Journal:  Nucleic Acids Res       Date:  1987-11-11       Impact factor: 16.971

6.  A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

Authors:  A P Feinberg; B Vogelstein
Journal:  Anal Biochem       Date:  1983-07-01       Impact factor: 3.365

7.  Structure-independent nucleotide sequence analysis.

Authors:  D R Mills; F R Kramer
Journal:  Proc Natl Acad Sci U S A       Date:  1979-05       Impact factor: 11.205

Review 8.  DNA regulatory elements for steroid hormones.

Authors:  M Beato; G Chalepakis; M Schauer; E P Slater
Journal:  J Steroid Biochem       Date:  1989-05       Impact factor: 4.292

9.  Isolation of a complementary DNA clone for the human complement protein C2 and its use in the identification of a restriction fragment length polymorphism.

Authors:  D E Woods; M D Edge; H R Colten
Journal:  J Clin Invest       Date:  1984-08       Impact factor: 14.808

10.  Identification of multiple HTF-island associated genes in the human major histocompatibility complex class III region.

Authors:  C A Sargent; I Dunham; R D Campbell
Journal:  EMBO J       Date:  1989-08       Impact factor: 11.598

View more
  16 in total

Review 1.  Mechanisms of viral pathogenesis in rheumatic disease.

Authors:  A Perl
Journal:  Ann Rheum Dis       Date:  1999-08       Impact factor: 19.103

2.  Retrotransposition of marked SVA elements by human L1s in cultured cells.

Authors:  Dustin C Hancks; John L Goodier; Prabhat K Mandal; Ling E Cheung; Haig H Kazazian
Journal:  Hum Mol Genet       Date:  2011-06-02       Impact factor: 6.150

3.  Evolutionary relationship between human major histocompatibility complex HLA-DR haplotypes.

Authors:  A C Svensson; N Setterblad; U Pihlgren; L Rask; G Andersson
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

4.  X-linked dyskeratosis congenita is predominantly caused by missense mutations in the DKC1 gene.

Authors:  S W Knight; N S Heiss; T J Vulliamy; S Greschner; G Stavrides; G S Pai; G Lestringant; N Varma; P J Mason; I Dokal; A Poustka
Journal:  Am J Hum Genet       Date:  1999-07       Impact factor: 11.025

5.  Germ cell expression of an isolated human endogenous retroviral long terminal repeat of the HERV-K/HTDV family in transgenic mice.

Authors:  A E Casau; J E Vaughan; G Lozano; A J Levine
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

6.  A genome-wide screen for normally methylated human CpG islands that can identify novel imprinted genes.

Authors:  Liora Z Strichman-Almashanu; Richard S Lee; Patrick O Onyango; Elizabeth Perlman; Folke Flam; Matthew B Frieman; Andrew P Feinberg
Journal:  Genome Res       Date:  2002-04       Impact factor: 9.043

7.  Ancestry of SINE-R.C2 a human-specific retroposon.

Authors:  Z B Zhu; B Jian; J E Volanakis
Journal:  Hum Genet       Date:  1994-05       Impact factor: 4.132

8.  The minimal active human SVA retrotransposon requires only the 5'-hexamer and Alu-like domains.

Authors:  Dustin C Hancks; Prabhat K Mandal; Ling E Cheung; Haig H Kazazian
Journal:  Mol Cell Biol       Date:  2012-09-24       Impact factor: 4.272

Review 9.  Human endogenous retroviruses and the nervous system.

Authors:  Renée N Douville; Avindra Nath
Journal:  Handb Clin Neurol       Date:  2014

10.  Human endogenous retrovirus (HERV-K) reverse transcriptase as a breast cancer prognostic marker.

Authors:  Maya Golan; Amnon Hizi; James H Resau; Neora Yaal-Hahoshen; Hadar Reichman; Iafa Keydar; Ilan Tsarfaty
Journal:  Neoplasia       Date:  2008-06       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.